Sanofi wins approval for first Bruton’s tyrosine kinase inhibitor in immune thrombocytopenia
1. The FDA approved rilzabrutinib, branded Wayrilz, as the first BTK (Bruton’s tyrosine kinase) inhibitor for adults with ITP (immune ...
1. The FDA approved rilzabrutinib, branded Wayrilz, as the first BTK (Bruton’s tyrosine kinase) inhibitor for adults with ITP (immune ...
1. In this cohort study of offspring born to mothers at risk for preterm delivery or diagnosed with an autoimmune ...
1. In this cohort study of offspring born to mothers at risk for preterm delivery or diagnosed with an autoimmune ...
1. Patients treated for septic shock with fludrocortisone and hydrocortisone were less likely to die or be discharged to hospice ...
1. Median overall survival was longer in patients receiving steroid-only treatment for adverse events associated with immune response. 2. Patients ...
1. This randomized controlled trial found that high dose methylprednisolone for 6-9 months reduced rates of significantly declining kidney function, ...
1. This randomized controlled trial found that high dose methylprednisolone for 6-9 months reduced rates of significantly declining kidney function, ...
1. Among a large cohort of children in Taiwan, oral corticosteroids prescribed for <14 days were associated with an increased ...
1. Among a large cohort of Danish adults, the use of potent or very potent topical corticosteroids was found to ...
1. In a study of children with pneumonia or sinusitis, opioids and corticosteroids were inappropriately prescribed more frequently in the ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.